Location: Home
  • search
  • go
  • Relate News
  • 12/8/2015How We Should Be Thinking About China's Healthcare Industry
  • 12/8/2015Chi-Med Initiates Phase III Trial of Fruquintinib for NSCLC in China
  • 12/8/2015China Healthcare: Missing A Beat (FT)
  • 12/8/2015WuXi PharmaTech and PRA Health Sciences Restructure Relationship in Ch...
  • 12/8/2015Aoxing Pharma Inaugurates Narcotic Drug R&D Center
  • 12/4/2015Recent Executive Moves
  • 12/4/2015Shanghai Synthetic Biology Innovation Alliance Established
  • 12/3/2015Nature's White Paper - Turning Point: Chinese Science in Transition
  • 12/3/2015China Expands Telemedicine Programs To Provinces
  • 12/3/2015CFDA Approves EV71 Vaccine against HFMD
  • 12/3/2015NHFPC Solicits Public Comments for the 13th FYP Health China Plan
  • 12/3/201514 Listed Firms among Pharma Companies Withdrawing Drug Registration A...
  • 12/3/2015Guangzhou Baiyunshan Pharma, AliHealth Enter Partnership for O2O Busin...
  • 12/2/2015Ascletis Secures US$20M Investment from Goldman Sachs
  • 12/2/2015CPIIC Releases Latest Chinese Pharma Data and Forecasts
  • 12/1/2015Huapont Life Sciences to Acquire Swiss Biological Medicine Group
  • 12/1/2015R&D Pharma Professionals in China Under the Microscope
  • 12/1/2015China Sees Rising Demands on Medical Affairs
  • 12/1/2015China's Western Medicine Foreign Trade Growth Slowed Further in 3Qs/20...
  • 12/1/2015Bayer Renews Drug Discovery Partnership with SIOC under CAS
  • 11/30/2015Eisai to Further Expand in China Through Acquisition of Liaoning Tiany...
  • 11/30/2015Oramed Inks Licensing Deal with Hefei Tianhui Incubator for Oral Insul...
  • 11/30/2015CDE Seeks Comments on New Bioequivalence Technical Guideline
  • 11/27/2015New Group Established Under CMA to Promote Precision Medicine for CVD
  • 11/27/2015Uni-Bio Buys Global Rights of Diabetes Drug from Jiangsu Hansoh
  • 11/26/2015First Pharma B2B Platform for Overstocked Medicines Approved in Guangd...
  • 11/25/2015NHFPC Outlines Healthcare Reform Tasks in the 13th FYP
  • 11/25/2015NHFPC Issues Guiding Policy for Community Healthcare
  • 11/24/2015Guangdong to Eliminate Drug Sales Margins at Urban Public Hospitals
  • 11/23/2015ZAI Lab, Hanmi Execute License Agreement for Novel Lung Cancer Drug in...
  • Page:218/359 Total number of articles:10756: [First][<<] [216] [217] [218] [219] [220] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group